Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers — Stella

Home/Alcohol Consumption/

View on ClinicalTrials.gov

Recruiting

Back to Alcohol Consumption trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

United States

Connecticut Mental Health Center (SAC and SATU), New Haven, Connecticut

Yale New Haven Hospital, New Haven, Connecticut

Key details

Phase

Early testing

Sponsor

Yale University

Collaborators

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Enrollment target

~63 participants

Started

July 2024

Primary completion

May 2026

Age range

21 Years – 50 Years

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.